Search the
company directory

Golf Basel AG 

Basel · Since 2005

The company's core activity is the operation of golf courses and the organization of golf events, including the rental of golf courses (green fees), the hosting of weddings and other events, gastronomy and the training of golfers in academies. Additionally, the company also offers the sale of golf articles and equipment, in particular from the brands Callaway and TaylorMade.

Golf Club de LaLargue 

Basel · Since 1996

The core activity of golf.ch is the marketing and provision of advertising opportunities in golf, particularly through the development and management of digital communication platforms and displays in golf courses. The company offers businesses and brands the opportunity to present their products and services to an exclusive target group of golfers. This also includes the production and marketing of golf magazines and the provision of advertising opportunities "on" and "off course".

Gönnerverein Stiftung für krebskranke Kinder, Regio Basiliensis 

Basel · Since 2020

Gönnerverein Stiftung für krebskranke Kinder, Regio Basiliensis provides financial direct aid to families of children with cancer, offers psycho-oncological support, funds paediatric cancer research and supports time-limited projects that improve affected families' quality of life.

Gotthelf Garage AG 

Basel · Since 1980

Gotthelf Garage AG is a car dealership specializing in the sale, maintenance and repair of Renault vehicles. The core activities include new car sales, used car sales, tire service, replacement car service, wheel alignment and suspension testing, air conditioning service, exhaust maintenance, bodywork, vehicle care and auto cosmetics, as well as the repair of vehicles of all brands.

Gottstein CETOGO Hotel Services 

Basel · Since 2015

CETOGO offers consulting and training services in the field of sales, particularly for small and medium-sized enterprises, hotels, and privately owned businesses. The core activities include: Building and developing sales departments, Training and coaching employees in customer contact, Developing sales strategies and measures, Conducting sales workshops and training, Consulting on the implementation of sales solutions. CETOGO positions itself as a mentor and coach, supporting companies in increasing their sales success by focusing on personal contact and employee motivation.

GPRS - Gombert Pharma Research Solutions 

Basel · Since 2016

GPRS - Gombert Pharma Research Solutions provides solutions and services for pharmaceutical research, including target analysis, druggability assessment, lead selection and PK/SAR data analysis. Its expertise covers computational chemistry, computational biology, drug design, project management and support for regulatory documentation and investigator brochures.

Grafik Atelier Erwin Schönholzer 

Basel · Since 2001

The core activity of the company "esc Erwin Schönholzer Grafik Atelier" is the creation of graphic design, illustrations, logos and brand identities, as well as the production of portraits and drawings. It is a graphic atelier that offers creative services in the field of visual communication.

Graf Ingenieure AG 

Basel · Since 2022

The company primarily focuses on planning and implementing building technology and architectural projects, particularly in the area of residential and commercial properties, with an emphasis on energy efficiency and sustainable solutions.

Grand Paysage GmbH 

Basel · Since 2018

The core activity of Grand Paysage GmbH is landscape architecture and urban planning. The company offers comprehensive services in these areas, including project planning, development and implementation, as well as consulting and expertise in the design of green spaces, urban climate and sustainable solutions.

Granite Bio AG 

Basel · Since 2021

Granite Bio AG is a biotechnology company developing first-in-class therapeutic antibodies for inflammatory, autoimmune and fibrotic diseases. Its pipeline includes GRT-001, an antibody that depletes pro-inflammatory monocytes and is in Phase 1b for inflammatory bowel disease, and GRT-002, an interleukin-3–blocking antibody in preclinical development expected to enter clinical trials in 2026.